Insider trading

Period: 120 months Stock: ALKS Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

47 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

47 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

47 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

47 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
47 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
47 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

47 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Aug 2026
Sold at will
$2.24M 44,472 at 50.35
74.3%
Sold half or more
2 Feb 2026
Cooke Shane Director
Sold on a plan 2×
$2.12M 61,200 at 34.57
37.1%
Planned (10b5-1)
13 Feb 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan 2×
$5.13M 144,419 at 35.53
71.4%
Sold half or more
12 Feb 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan 2×
$6.72M 204,921 at 32.78
78.0%
Sold half or more
30 Jan 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan
$3.23M 100,918 at 32.05
69.5%
Sold half or more
9 Dec 2024
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan
$1.96M 61,151 at 32.07
56.2%
Sold half or more
11 Nov 2024
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan
$1.77M 58,996 at 30.08
41.5%
Planned (10b5-1)
9 May 2023
Wysenski Nancy Director
Sold on a plan
$1.29M 41,250 at 31.24
72.3%
Sold half or more
17 May 2022
LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc.
Sold, plan not stated
$1.46M 50,000 at 29.15
17.7%
6 May 2022
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$2.61M 93,747 at 27.85
8.8%
5 May 2022
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$7.11M 253,510 at 28.03
21.2%
20 Apr 2022
Jackson Blair Curtis EVP, Chief Operating Officer
Sold, plan not stated
$1.48M 49,999 at 29.61
36.3%
19 Aug 2021
Brown Iain Michael SVP, Chief Financial Officer
Sold, plan not stated
$1.20M 40,000 at 29.99
48.2%
18 May 2021
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$3.29M 150,000 at 21.90
15.9%
17 May 2021
LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc.
Sold, plan not stated
$1.10M 50,000 at 22.09
18.7%
11 May 2021
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$3.31M 150,000 at 22.09
15.9%
6 May 2021
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$2.18M 100,000 at 21.79
11.2%
14 May 2020
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.13M 75,000 at 15.00
9.0%
26 Mar 2020
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.08M 75,000 at 14.36
9.0%
19 Mar 2020
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 3×
$1.09M 75,000 at 14.47
9.0%
14 Nov 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.95M 100,000 at 19.50
12.2%
7 Nov 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.38M 69,795 at 19.81
8.9%
19 Sep 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$2.15M 100,000 at 21.54
12.2%
12 Sep 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$2.27M 100,000 at 22.68
12.2%
5 Sep 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$2.02M 100,000 at 20.18
12.2%
23 May 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.21M 50,000 at 24.22
6.5%
16 May 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.53M 60,000 at 25.42
7.7%
12 Mar 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.47M 44,171 at 33.24
5.8%
5 Mar 2019
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.68M 50,000 at 33.63
6.5%
15 May 2018
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$2.32M 50,000 at 46.38
7.0%
8 May 2018
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$2.22M 50,000 at 44.32
7.0%
1 May 2018
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$2.20M 50,000 at 44.02
7.0%
2 Feb 2018
Cooke Shane President, Alkermes plc
Sold, plan not stated 2×
$4.41M 72,793 at 60.55
49.4%
29 Nov 2017
FRATES JAMES M SVP, Alks Inc; CFO ALKS
Sold, plan not stated 2×
$1.06M 20,932 at 50.51
12.7%
2 Nov 2017
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$2.44M 50,000 at 48.87
7.3%
24 May 2017
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated
$1.44M 25,000 at 57.42
3.8%
17 May 2017
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 3×
$2.91M 50,000 at 58.19
7.3%
10 May 2017
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$1.43M 25,000 at 57.29
3.8%
7 Mar 2017
FRATES JAMES M SVP, Alks Inc; CFO ALKS
Sold, plan not stated 2×
$1.48M 25,000 at 59.08
17.4%
2 Mar 2017
Cooke Shane President, Alkermes plc
Sold, plan not stated
$1.20M 20,000 at 60.00
22.4%
14 Dec 2016
FRATES JAMES M SVP, Alks Inc; CFO ALKS
Sold, plan not stated 2×
$1.37M 25,000 at 54.73
18.2%
7 Dec 2016
FRATES JAMES M SVP, Alks Inc; CFO ALKS
Sold, plan not stated 3×
$1.34M 23,731 at 56.28
17.4%
29 Nov 2016
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$1.71M 30,000 at 56.98
4.7%
22 Nov 2016
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$1.76M 30,000 at 58.66
4.7%
15 Nov 2016
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$1.76M 30,000 at 58.82
4.7%
10 Nov 2016
BREYER ROBERT A Director
Sold, plan not stated
$1.20M 20,000 at 60.00
56.9%
Sold half or more
8 Nov 2016
POPS RICHARD F Director and CEO, Alkermes plc
Sold, plan not stated 2×
$1.60M 30,000 at 53.28
4.7%
Showing 1–47 of 47.